Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Jack F. Shern(National Institutes of Health), Javed Khan(Kent State University), Xinyu Wen(National Institutes of Health), Stephen X. Skapek(Duke University), Erin R. Rudzinski(Indiana University School of Medicine), Marielle E. Yohe(National Cancer Center), Julia Chisholm(Royal Marsden NHS Foundation Trust), Donald A. Barkauskas(University of Southern California), Michael Hubank(Royal Marsden Hospital), Joanna Selfe(Institute of Cancer Research), Elisa Izquierdo(Institute of Cancer Research), Kristine Jones(Leidos (United States)), Jun S. Wei(Center for Cancer Research), Susanne A. Gatz(Institute of Cancer Research), Corinne M. Linardic(Duke University), Anna Kelsey, Sally L. George(Royal Marsden NHS Foundation Trust), Meriel Jenney(Noah's Ark Children's Hospital for Wales), Louis Chesler(Institute of Cancer Research), Belynda Hicks(Frederick National Laboratory for Cancer Research), Rajesh Patidar, Hsien-Chao Chou(National Cancer Institute), Sabri Jamal(Royal Marsden NHS Foundation Trust), Debbie Hughes, Young Song(University of British Columbia), Douglas S. Hawkins(Seattle Children's Hospital), Tammy Lo(Children's Oncology Group), Rebecca Brown(Institute of Cancer Research), Paola Angelini(Istituto Giannina Gaslini), Janet Shipley(Institute of Cancer Research), David Hall(Children's Oncology Group), Sivasish Sindiri(National Institutes of Health)
Journal of Clinical Oncology
June 24, 2021
Cited by 221


Related Papers